Equities

Advanced Enzyme Technologies Ltd

ADVENZYMES:NSI

Advanced Enzyme Technologies Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)538.05
  • Today's Change18.05 / 3.47%
  • Shares traded533.99k
  • 1 Year change+66.12%
  • Beta0.4648
Data delayed at least 15 minutes, as of Sep 20 2024 11:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments5,4804,8483,781
Total Receivables, Net1,0341,062997
Total Inventory1,5241,2811,239
Prepaid expenses402321
Other current assets, total206.895.81
Total current assets8,0977,2216,044
Property, plant & equipment, net3,0732,8882,718
Goodwill, net3,2533,2092,961
Intangibles, net583609663
Long term investments1.651.650.65
Note receivable - long term148122148
Other long term assets424328
Total assets15,35514,21812,676
LIABILITIES
Accounts payable158242179
Accrued expenses272108104
Notes payable/short-term debt1765019
Current portion long-term debt/capital leases696162
Other current liabilities, total389314240
Total current liabilities1,064776604
Total long term debt228224265
Total debt473335346
Deferred income tax343372393
Minority interest347375430
Other liabilities, total8.865.0611
Total liabilities1,9911,7521,703
SHAREHOLDERS EQUITY
Common stock224224224
Additional paid-in capital821821814
Retained earnings (accumulated deficit)10,87110,0689,123
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1,4481,354813
Total equity13,36412,46710,974
Total liabilities & shareholders' equity15,35514,21812,676
Total common shares outstanding112112112
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.